Experience in the Use of Valdoxan in the Treatment of Post-Stroke Depression


Valdoxan at a dose of 25 mg per day for three months was used in 40 patients aged 55–85 years with post-stroke depression. Patients’ status was assessed clinically and in terms of a series of scales (Hamilton, MMSE, Tinnetti, etc.). High antidepressant efficacy and good tolerance were demonstrated. On the background of stabilization of the emotional… (More)
DOI: 10.1007/s11055-012-9600-4


2 Figures and Tables